1.Granular Cell Tumor of the Male Breast With Nipple Retraction and Pectoralis Major Invasion Treated With Mastectomy: A Case Report
Sang Chun PARK ; Yong Bin KWON ; Sang Yun AN ; Hye Un MA ; Seo Won JUNG ; Yong Min NA ; Young Jae RYU ; Hyo Jae LEE ; Hyo Soon LIM ; Ji Shin LEE ; Jin Seong CHO ; Min Ho PARK
Journal of Breast Disease 2024;12(1):19-22
		                        		
		                        			
		                        			 Granular cell tumor is a rare disease, and it is even rarer in the male breast. Although it is typically a benign tumor, due to its features and image findings, it can be easily misdiagnosed and managed as a malignant tumor. Therefore, the extent of the surgery can inappropriately be expanded. To avoid misdiagnosis and overtreatment, surgeons must perform a careful evaluation. We describe a case of a granular cell tumor of the male breast treated with mastectomy. 
		                        		
		                        		
		                        		
		                        	
2.Clinical Practice Guidelines for Oropharyngeal Dysphagia
Seoyon YANG ; Jin-Woo PARK ; Kyunghoon MIN ; Yoon Se LEE ; Young-Jin SONG ; Seong Hee CHOI ; Doo Young KIM ; Seung Hak LEE ; Hee Seung YANG ; Wonjae CHA ; Ji Won KIM ; Byung-Mo OH ; Han Gil SEO ; Min-Wook KIM ; Hee-Soon WOO ; Sung-Jong PARK ; Sungju JEE ; Ju Sun OH ; Ki Deok PARK ; Young Ju JIN ; Sungjun HAN ; DooHan YOO ; Bo Hae KIM ; Hyun Haeng LEE ; Yeo Hyung KIM ; Min-Gu KANG ; Eun-Jae CHUNG ; Bo Ryun KIM ; Tae-Woo KIM ; Eun Jae KO ; Young Min PARK ; Hanaro PARK ; Min-Su KIM ; Jungirl SEOK ; Sun IM ; Sung-Hwa KO ; Seong Hoon LIM ; Kee Wook JUNG ; Tae Hee LEE ; Bo Young HONG ; Woojeong KIM ; Weon-Sun SHIN ; Young Chan LEE ; Sung Joon PARK ; Jeonghyun LIM ; Youngkook KIM ; Jung Hwan LEE ; Kang-Min AHN ; Jun-Young PAENG ; JeongYun PARK ; Young Ae SONG ; Kyung Cheon SEO ; Chang Hwan RYU ; Jae-Keun CHO ; Jee-Ho LEE ; Kyoung Hyo CHOI
Journal of the Korean Dysphagia Society 2023;13(2):77-106
		                        		
		                        			 Objective:
		                        			Dysphagia is a common clinical condition characterized by difficulty in swallowing. It is sub-classified into oropharyngeal dysphagia, which refers to problems in the mouth and pharynx, and esophageal dysphagia, which refers to problems in the esophageal body and esophagogastric junction. Dysphagia can have a significant negative impact one’s physical health and quality of life as its severity increases. Therefore, proper assessment and management of dysphagia are critical for improving swallowing function and preventing complications. Thus a guideline was developed to provide evidence-based recommendations for assessment and management in patients with dysphagia. 
		                        		
		                        			Methods:
		                        			Nineteen key questions on dysphagia were developed. These questions dealt with various aspects of problems related to dysphagia, including assessment, management, and complications. A literature search for relevant articles was conducted using Pubmed, Embase, the Cochrane Library, and one domestic database of KoreaMed, until April 2021. The level of evidence and recommendation grade were established according to the Grading of Recommendation Assessment, Development and Evaluation methodology. 
		                        		
		                        			Results:
		                        			Early screening and assessment of videofluoroscopic swallowing were recommended for assessing the presence of dysphagia. Therapeutic methods, such as tongue and pharyngeal muscle strengthening exercises and neuromuscular electrical stimulation with swallowing therapy, were effective in improving swallowing function and quality of life in patients with dysphagia. Nutritional intervention and an oral care program were also recommended. 
		                        		
		                        			Conclusion
		                        			This guideline presents recommendations for the assessment and management of patients with oropharyngeal dysphagia, including rehabilitative strategies. 
		                        		
		                        		
		                        		
		                        	
3.Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies
Jee Hyung LEE ; Haeryoung KIM ; Sang Hyub LEE ; Ja-Lok KU ; Jung Won CHUN ; Ha Young SEO ; Soon Chan KIM ; Woo Hyun PAIK ; Ji Kon RYU ; Sang Kook LEE ; Andrew M. LOWY ; Yong-Tae KIM
Gut and Liver 2022;16(4):625-636
		                        		
		                        			 Background/Aims:
		                        			Three-dimensional cultures of human pancreatic cancer tissue also known as “organoids” have largely been developed from surgical specimens. Given that most patients present with locally advanced and/or metastatic disease, such organoids are not representative of the majority of patients. Therefore, we used endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) to collect pancreatic cancer tissues from patients with advanced pancreatic cancer to create organoids, and evaluated their utility in pancreatic cancer research. 
		                        		
		                        			Methods:
		                        			Single-pass EUS-FNA samplings were employed to obtain the tissue for organoid generation. After establishment of the organoid, we compared the core biopsy tissues with organoids using hematoxylin and eosin staining, and performed whole exome sequencing (WES) to detect mutational variants. Furthermore, we compared patient outcome with the organoid drug response to determine the potential utility of the clinical application of such organoid-based assays. 
		                        		
		                        			Results:
		                        			Organoids were successfully generated in 14 of 20 tumors (70%) and were able to be passaged greater than 5 times in 12 of 20 tumors (60%). Among them, we selected eight pairs of organoid and core biopsy tissues for detailed analyses. They showed similar patterns in hematoxylin and eosin staining. WES revealed mutations in KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 which were 93% homologous, and the mean nonreference discordance rate was 5.47%. We observed moderate drug response correlations between the organoids and clinical outcomes in patients who underwent FOLFIRINOX chemotherapy. 
		                        		
		                        			Conclusions
		                        			The established organoids from EUS-FNA core biopsies can be used for a suitable model system for pancreatic cancer research 
		                        		
		                        		
		                        		
		                        	
4.Guidelines for Safe Drug Use
Su Hyun KIM ; Hye-Kyung JUNG ; Ein-Soon SHIN ; Jin Seo LEE ; Yon Ju RYU ; Kyoung Sup HONG ; Soo Mee BANG ; Yoon-Seok CHANG ; Chan Kyu KIM ; Byung Wan LEE ; Seung-Jae HONG ; Chang Oh KIM ;
Korean Journal of Medicine 2021;96(3):225-235
		                        		
		                        			Background/Aims:
		                        			In Korea, medications are available by prescription from a physician, or can be purchased over-the-counter (OTC) without a prescription. Education regarding both prescribed and OTC drugs is important to minimize side effects and avoid drug abuse. The risk of side effects due to polypharmacy is increasing due to the growing number of elderly patients with comorbidities. 
		                        		
		                        			Methods:
		                        			There are various clinical guidelines for physicians, but it is difficult for patients and their caregivers to find published guidelines regarding drug use. In this regard, experts from nine subspecialties of internal medicine, geriatric medicine, and guideline development methodology formed a working group to develop guidelines for safe drug use under the Clinical Practice Guidelines Committee of the Korean Association of Internal Medicine. 
		                        		
		                        			Results:
		                        			The main contents of this guideline are 1) safe and effective drug administration, 2) the proper use of analgesics (acetaminophen and nonsteroidal anti-inflammatory drugs), 3) the proper use of tranquilizers and sleeping pills to prevent drug abuse, 4) points to be aware of when taking multiple medications. 
		                        		
		                        			Conclusions
		                        			The guidelines were developed for patients and their caregivers to understand the general principles and precautions for drug use, including commonly used painkillers, mood stabilizers, sleeping pills, and polypharmacy. These guidelines could also be used as educational materials for physicians, nurses, and healthcare workers to educate patients and their caregivers.
		                        		
		                        		
		                        		
		                        	
5.Guidelines for Safe Drug Use
Su Hyun KIM ; Hye-Kyung JUNG ; Ein-Soon SHIN ; Jin Seo LEE ; Yon Ju RYU ; Kyoung Sup HONG ; Soo Mee BANG ; Yoon-Seok CHANG ; Chan Kyu KIM ; Byung Wan LEE ; Seung-Jae HONG ; Chang Oh KIM ;
Korean Journal of Medicine 2021;96(3):225-235
		                        		
		                        			Background/Aims:
		                        			In Korea, medications are available by prescription from a physician, or can be purchased over-the-counter (OTC) without a prescription. Education regarding both prescribed and OTC drugs is important to minimize side effects and avoid drug abuse. The risk of side effects due to polypharmacy is increasing due to the growing number of elderly patients with comorbidities. 
		                        		
		                        			Methods:
		                        			There are various clinical guidelines for physicians, but it is difficult for patients and their caregivers to find published guidelines regarding drug use. In this regard, experts from nine subspecialties of internal medicine, geriatric medicine, and guideline development methodology formed a working group to develop guidelines for safe drug use under the Clinical Practice Guidelines Committee of the Korean Association of Internal Medicine. 
		                        		
		                        			Results:
		                        			The main contents of this guideline are 1) safe and effective drug administration, 2) the proper use of analgesics (acetaminophen and nonsteroidal anti-inflammatory drugs), 3) the proper use of tranquilizers and sleeping pills to prevent drug abuse, 4) points to be aware of when taking multiple medications. 
		                        		
		                        			Conclusions
		                        			The guidelines were developed for patients and their caregivers to understand the general principles and precautions for drug use, including commonly used painkillers, mood stabilizers, sleeping pills, and polypharmacy. These guidelines could also be used as educational materials for physicians, nurses, and healthcare workers to educate patients and their caregivers.
		                        		
		                        		
		                        		
		                        	
6.The Effects of a Simulation-Based High Flow Nasal Cannula Oxygen Therapy Training Program on the Knowledge, Clinical Performance and Educational Satisfaction of Clinical Nurses
Kyung Soon JANG ; Kyeong Hee RYU ; Hyeon Mo KANG ; In Hwa KANG ; Jeong Hui KWON ; Gyeong Mi LEE ; Yun Jung NAM ; Mi Hye SEO ; Ji Yeon KIM ; Ji Yun JUNG ; Hyun Ji KIM ; Hye Min BAE
Journal of Korean Clinical Nursing Research 2020;26(1):47-58
		                        		
		                        			 Purpose:
		                        			The aim of this study was to develop a simulation-based High Flow Nasal Cannula Oxygen Therapy training program based on NLN/ISF to identify the effect on knowledge, clinical performance, and educational satisfaction compared to a group who had traditional High Flow Nasal Cannula Oxygen Therapy training after applying it to clinical nurses.  
		                        		
		                        			Methods:
		                        			31 experimental groups and 33 control groups were conducted from August 2019 to September 2019 for inexperienced nurses over 4 months to 5 years with no experience using high-flow oxygen therapy. Educational programs were developed in scenarios according to Airvo2 and Optiflow, such as facilitator, participant, educational condition, design, characteristics, and educational outcomes. The education application was conducted in advanced for knowledge and clinical performance ability after watching therapy video. Since then, a total of 90 minutes have been conducted for respiratory failure theory training, airvo2 and optiflow simulation training, and debriefing. After applying the education, the medical institution measured nurses’ knowledge, clinical performance, and education satisfaction. Data were analyzed using descriptive statistics, with the SPSS/WIN 22.0 program.  
		                        		
		                        			Results:
		                        			Both knowledge and educational satisfaction were higher in the experimental group than in the control group (t=-14.09, p<.001), (t=-12.99, p<.001). The clinical performance for both use of Optiflow and Airvo2 were higher in the experimental group than in the control group (t=-11.39, p<.001), (t=-11.38, p<.001) .  
		                        		
		                        			Conclusion
		                        			Results showed that the simulation-based High Flow Nasal Cannula Oxygen Therapy training was effective with the experimental group having increased scores for every area of this study. 
		                        		
		                        		
		                        		
		                        	
7.Adaptation of Isolation Guidelines for Health Care Settings
Jae Geum RYU ; Jae Sim JEONG ; Ihn Sook JEONG ; Jeong Hye KIM ; Eun Young HONG ; Hyang Sook KIM ; Young Sun JUNG ; Jeong Soon KWON ; Ji Young LEE ; Ji Youn CHOI ; Kyung Sug KIM ; Eun Hyun KIM ; Gyeong Suk CHA ; Eun Jin KIM ; Kyung Hee PARK ; Hyun Ju SEO
Journal of Korean Clinical Nursing Research 2018;24(2):209-226
		                        		
		                        			
		                        			PURPOSE: This purpose of this study was to develop evidence-based practice guideline for isolation in health care settings to prevent transmission of infectious diseases utilizing guideline adaption process. METHODS: The process of guideline adaptation was performed according to the Korean hospital nurses association's guideline adaptation manual which consisted of three main phases, 9 modules, and 24 steps. RESULTS: The adapted isolation guideline consisted of introduction, overview of isolation guideline, summary of recommendations, recommendations, references, and appendices. The guideline includes 224 recommendations in 4 sections which are organizational administration, standard precautions, transmission-based precautions, and education/counselling. CONCLUSION: The adapted isolation guideline is recommended to be disseminated and utilized by nurses and clinicians nationwide to improve the isolation practices for infected or colonized patients with communicable diseases and to decrease the transmission of infections in the healthcare settings.
		                        		
		                        		
		                        		
		                        			Colon
		                        			;
		                        		
		                        			Communicable Diseases
		                        			;
		                        		
		                        			Delivery of Health Care
		                        			;
		                        		
		                        			Disease Transmission, Infectious
		                        			;
		                        		
		                        			Evidence-Based Nursing
		                        			;
		                        		
		                        			Evidence-Based Practice
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Infection Control
		                        			;
		                        		
		                        			Patient Isolation
		                        			
		                        		
		                        	
8.Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients.
Sun Young YIM ; Tae Hyung KIM ; Suh Sang JUN ; Eun Sun KIM ; Bora KEUM ; Yeon Seok SEO ; Hyung Joon YIM ; Yoon Tae JEEN ; Hoon Jai CHUN ; Hong Sik LEE ; Soon Ho UM ; Chang Duck KIM ; Nam Hee WON ; Ho Sang RYU
Gut and Liver 2017;11(3):417-425
		                        		
		                        			
		                        			BACKGROUND/AIMS: We aimed to clarify the association of hepatitis B surface antigen (HBsAg)/hepatitis B core antigen (HBcAg) with the disease status and treatment response in patients with chronic hepatitis B (CHB). METHODS: We investigated 171 biopsy-proven entecavir-treated CHB patients (109 hepatitis B e antigen [HBeAg]-positive, 62 HBeAg-negative). HBcAg expression was positive when ≥10% of hepatocytes stained, and classified into nuclear, mixed, and cytoplasmic patterns. HBsAg expressions were intracytoplasmic (diffuse, globular, and submembranous) and membranous. The histologic activity index (HAI) and fibrosis stage followed Ishak system. RESULTS: In HBeAg-positive patients, older age, increased HAI score, advanced fibrosis, and reduced viral load were observed when HBcAg expression shifted from nucleus to cytoplasm in HBcAg-positive patients, and HBsAg expression from non-submembranous to submembranous in HBcAg-negative patients (all, p<0.05). In HBeAg-negative patients, only intracytoplasmic HBsAg expression patterns had clinical relevance with decreased ALT levels and viremia. In HBeAg-positive patients without favorable predictors of virologic response, negative HBcAg and membranous HBsAg expression predicted greater virologic response (both, p<0.05). The probability of HBeAg seroclearance was higher in patients with increased HAI or lacking HBcAg expression (both, p<0.05). Higher serum HBsAg levels and hepatocyte HBcAg positivity were associated with reduced serum HBsAg during first and post-first year treatment, respectively (both, p<0.05). CONCLUSIONS: Hepatocyte HBcAg/HBsAg expression is a good marker for disease status and predicting treatment response.
		                        		
		                        		
		                        		
		                        			Cytoplasm
		                        			;
		                        		
		                        			Fibrosis
		                        			;
		                        		
		                        			Hepatitis B Core Antigens*
		                        			;
		                        		
		                        			Hepatitis B e Antigens
		                        			;
		                        		
		                        			Hepatitis B Surface Antigens*
		                        			;
		                        		
		                        			Hepatitis B*
		                        			;
		                        		
		                        			Hepatitis B, Chronic*
		                        			;
		                        		
		                        			Hepatitis*
		                        			;
		                        		
		                        			Hepatitis, Chronic*
		                        			;
		                        		
		                        			Hepatocytes*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Viral Load
		                        			;
		                        		
		                        			Viremia
		                        			
		                        		
		                        	
9.Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
Seung Woon PARK ; Soon Ho UM ; Han Ah LEE ; Sang Hyun KIM ; Yura SIM ; Sun Young YIM ; Yeon Seok SEO ; Ho Sang RYU
Clinical and Molecular Hepatology 2016;22(2):281-285
		                        		
		                        			
		                        			Autoimmune hepatitis (AIH) is an immune-mediated chronic liver disease characterized by hepatocellular inflammation, necrosis, and fibrosis, which can progress to cirrhosis and fulminant hepatic failure. The standard treatment for AIH includes corticosteroids alone or in combination with azathioprine. Although most patients achieve remission using the standard regimen, some patients do not respond due to either drug intolerance or refractory disease; in such cases alternative immunosuppressive agents should be explored. The second-line therapies are cyclophilin inhibitors such as cyclosporine A or tacrolimus, and nowadays mycophenolate mofetil (MMF) is widely used if azathioprine-based therapies are not tolerated. Although these are recommended as an alternative to the first-line regimen, there is insufficient evidence for the efficacy of second-line therapies, with the evidence based mainly on expert opinion. Therefore, we report an AIH patient receiving the standard regimen in whom remission did not occur due to side effects to azathioprine, but was successfully treated with MMF in combination with corticosteroids as an alternative to the standard regimen.
		                        		
		                        		
		                        		
		                        			Alanine Transaminase/analysis
		                        			;
		                        		
		                        			Alopecia/etiology
		                        			;
		                        		
		                        			Antibiotics, Antineoplastic/*therapeutic use
		                        			;
		                        		
		                        			Aspartate Aminotransferases/analysis
		                        			;
		                        		
		                        			Azathioprine/adverse effects
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hepatitis, Autoimmune/*drug therapy/pathology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liver/enzymology/pathology
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Mycophenolic Acid/*therapeutic use
		                        			;
		                        		
		                        			Pancytopenia/etiology
		                        			;
		                        		
		                        			Prednisolone/therapeutic use
		                        			
		                        		
		                        	
10.Caroli's disease misdiagnosed as intraductal papillary neoplasm of the bile duct.
Dae Hoe GU ; Min Seon PARK ; Chang Ho JUNG ; Yang Jae YOO ; Jae Young CHO ; Yun Ho LEE ; Yeon Seok SEO ; Hyung Joon YIM ; Soon Ho UM ; Ho Sang RYU
Clinical and Molecular Hepatology 2015;21(2):175-179
		                        		
		                        			
		                        			Caroli's disease is a rare autosomal-recessive disorder caused by malformation of the ductal plate during embryonic development. Although it is present at birth, Caroli's disease is typically not diagnosed until between the second and fourth decades of life, as it was in the present patient. Here we report a rare case of Caroli's disease limited to one liver segment, which was initially misdiagnosed as an intraductal papillary neoplasm of the bile duct. The asymptomatic patient was treated with liver segmentectomy.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Bile Duct Neoplasms/diagnosis/pathology
		                        			;
		                        		
		                        			Bile Ducts, Intrahepatic
		                        			;
		                        		
		                        			Caroli Disease/*diagnosis/pathology
		                        			;
		                        		
		                        			Diagnostic Errors
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Magnetic Resonance Imaging
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Tomography, X-Ray Computed
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail